Aurinia Pharmaceuticals Announces NICE Recommendation of LUPKYNIS® For Adults with Active Lupus Nephritis Life Science Investing
RYALTRIS®, a new combination prescription nasal spray for moderate to severe seasonal allergic rhinitis , now available across Canada Pharmaceutical Investing
ISS Joins Glass Lewis in Recommending Aurinia Shareholders Vote "FOR" ALL Company Director Nominees at 2023 Annual General Meeting Life Science Investing
Albert Labs Receives preliminary acceptance of 35 Novel Inventive Claims for Patent Protected Manufacturing Technology Pharmaceutical Investing
Thermo Fisher Scientific to Present at BofA Securities 2023 Healthcare Conference on May 10th, 2023 Medical Device Investing
American Medical Association to Issue First New Code for Psychedelic Therapies Psychedelics Investing
